Medical Services Advisory Committee - Applications scheduled to be considered
- 1627 - Point-of-care testing for sexually transmitted infections provided by Aboriginal Medical Services or Aboriginal Community Controlled Heath Services in rural or remote areas
- 1629 – Defensive Antibacterial Coating (DAC) 5ml Kit
- 1662.1 – The reduction of mitral regurgitation through tissue approximation using transvenous/transeptal techniques
- 1669 – WITHDRAWN - KRAS G12C variant testing to determine eligibility for PBS-subsidised sotorasib second-line therapy in patients with locally advanced or metastatic non small cell lung cancer
- 1675 - Whole Genome Sequencing for the diagnosis of mitochondrial disease
- 1680 - Genetic testing for childhood hearing impairment
- 1684 - Genetic testing for variants associated with haematological malignancies
- 1685 - Ventral rectopexy for the treatment of rectal prolapse and intussusception
- 1691 - PromarkerD testing in patients with type 2 diabetes to determine the risk of developing diabetic kidney disease
- 1707 – Detection of measurable residual disease in patients with acute lymphoblastic leukaemia
- 1718 - WITHDRAWN - PD-L1 immunohistochemistry testing for persistent, recurrent, or metastatic cervical cancer, to determine eligibility for pembrolizumab treatment
- 1721 – Small gene panel testing for non-small cell lung carcinoma
- 1723 - Brexucabtagene autoleucel for adult relapsed or refractory B-precursor acute lymphoblastic leukaemia
Consultation Input:MSAC values consultation input from individuals and organisations with an interest in an application that it is considering, including experience of the medical conditions, services or technologies being addressed by the application.
It is anticipated that the above-mentioned applications will proceed to MSAC in November 2022. Consultation input must be received by no later than Friday, 7 October 2022 for it to be considered by MSAC. A Consultation Survey Form is available on the relevant application webpage.
Further information on MSAC’s consultation process is also available on the MSAC website.